cignadefa14a.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant x
Filed by a Party other than the Registrant ¨

Check the appropriate box:
¨ Preliminary Proxy Statement
¨ Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨ Definitive Proxy Statement
x Definitive Additional Materials
¨ Soliciting Materials Pursuant to sec. 240.14a-11(c) or sec. 240.14a-12
 
Cigna Corporation
______________________________
(Exact Name of Registrant as Specified in its Charter)

Payment of Filing Fee (Check the appropriate box)
x No fee required.
¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(l) and 0-11.1
 
(1)   Title of each class of securities to which transaction applies:
________________________________________________________________________________
(2)   Aggregate number of securities to which transaction applies:
________________________________________________________________________________
(3)   Per unit or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
________________________________________________________________________________
(4)   Proposed maximum aggregate value of transaction:
________________________________________________________________________________
(5)   Total fee paid:
________________________________________________________________________________

¨ Fee paid previously with preliminary materials.
¨ Check box if any part of the fee is offset as provided by Exchange Act Tule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
(1)   Amount Previously Paid
________________________________________________________________________________
(2)   Form, Schedule or Registration Statement No.:
________________________________________________________________________________
(3)   Filing Party:
________________________________________________________________________________
(4)   Date Filed:
________________________________________________________________________________
 
1


 
 
 
CIGNA Corporation
Two Liberty Place
1601 Chestnut Street
Philadelphia, PA 19192-1550
April 10, 2008
To Our Investors:
 
In anticipation of CIGNA Corporation’s annual meeting of shareholders to be held on Wednesday, April 23, 2008, you have been asked to vote on three separate proposals to amend CIGNA Corporation’s Restated Certificate of Incorporation.  Each of these proposed amendments has been approved by the Board of Directors and, together, they reflect the Company’s continued commitment to implementing good corporate governance practices. Institutional Shareholder Services (ISS) has recommended a FOR vote on each of the proposals described below and we urge you to vote your shares in favor of these proposed amendments.
 
Approve the amendment of Article Fourth of the Company’s Restated Certificate of Incorporation
 
Currently, the Restated Certificate of Incorporation includes provisions related to Junior Participating Preferred Stock, Series D that was created to be issued under the Company’s Shareholder Rights Agreement.  The Shareholder Rights Agreement expired on August 4, 2007; therefore the Board of Directors has approved an amendment to Article Fourth of the Restated Certificate of Incorporation that would delete the provisions related to the Junior Participating Preferred Stock, Series D.  CIGNA must obtain shareholder approval of this proposal in order to amend the Restated Certificate of Incorporation.
 
Approve the amendment of Article Fifth of the Company’s Restated Certificate of Incorporation
 
In October, 2007, the Board approved the amendment of Article Fifth of CIGNA's Restated Certificate of Incorporation to replace the 80% supermajority voting requirement relating to any amendment of the By-Laws by CIGNA’s shareholders (other than an amendment to Article Three, Section Two of the By-Laws which concerns number, qualifications, election and term of office for CIGNA’s Board of Directors), with a simple majority voting requirement. CIGNA must obtain shareholder approval of this proposal in order to amend the Restated Certificate of Incorporation.
 
Approve the amendment of Article Tenth of the Company’s Restated Certificate of Incorporation
 
In October, 2007, the Board also approved amendments to Article Tenth of the Company’s Restated Certificate of Incorporation that would replace certain supermajority voting requirements with a simple majority voting requirement. These proposed amendments provide for a simple majority voting requirement to replace the eighty percent (80%) supermajority voting requirement relating to (1) the approval of certain business combinations, as defined in the Restated Certificate of Incorporation, and (2) any amendment of Article Tenth of the Company’s Certificate of Incorporation. CIGNA must obtain shareholder approval of this proposal in order to amend the Restated Certificate of Incorporation.
 
Each of the proposed amendments to the Company’s Restated Certificate of Incorporation described above is also described in the Proxy Statement. The Restated Certificate of Incorporation itself, as proposed to be amended, is included as Exhibit B to the Proxy Statement. CIGNA’s 2008 Proxy Statement and 2007 Annual Report to Shareholders are available online at http://www.cigna.com/about_us/investor_relations/recent_disclosures.html. You may also contact CIGNA’s Shareholder Services Department at 215.761.3516 for additional copies of the Proxy Statement and/or Annual Report.
 
2

 
We appreciate the opportunity to share with you our reasons for proposing these changes to CIGNA's Restated Certificate of Incorporation and to reiterate CIGNA's commitment to good corporate governance. If you would like to discuss the proposals or any other matters referred to in this letter, please contact either of us.
 

 
Sincerely,
 

 
 
/s/ Nicole Jones    
NICOLE S. JONES
Corporate Secretary
CIGNA Corporation
Two Liberty Place
1601 Chestnut Street
Philadelphia, PA 19192-1550
(215) 761-3713
 
/s/ Ted Detrick
TED DETRICK
Vice President, Investor Relations
CIGNA Corporation
Two Liberty Place
1601 Chestnut Street
Philadelphia, PA 19192-1550
(215) 761-1414

 

 
3